Howard Ceri
Queen's University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Howard Ceri.
Applied and Environmental Microbiology | 2005
Kerry L. Tomlin; Rebecca J. Malott; Gordon Ramage; Douglas G. Storey; Pamela A. Sokol; Howard Ceri
ABSTRACT Biofilm formation in Burkholderia cenocepacia has been shown to rely in part on acylhomoserine lactone-based quorum sensing. For many other bacterial species, it appears that both the initial adherence and the later stages of biofilm maturation are affected when quorum sensing pathways are inhibited. In this study, we examined the effects of mutations in the cepIR and cciIR quorum-sensing systems of Burkholderia cenocepacia K56-2 with respect to biofilm attachment and antibiotic resistance. We also examined the role of the cepIR system in biofilm stability and structural development. Using the high-throughput MBEC assay system to produce multiple equivalent biofilms, the biomasses of both the cepI and cepR mutant biofilms, measured by crystal violet staining, were less than half of the value observed for the wild-type strain. Attachment was partially restored upon providing functional gene copies via multicopy expression vectors. Surprisingly, neither the cciI mutant nor the double cciI cepI mutant was deficient in attachment, and restoration of the cciI gene resulted in less attachment than for the mutants. Meanwhile, the cciR mutant did show a significant reduction in attachment, as did the cciR cepIR mutant. While there was no change in antibiotic susceptibility with the individual cepIR and cciIR mutants, the cepI cciI mutant biofilms were more sensitive to ciprofloxacin. A significant increase in sensitivity to removal by sodium dodecyl sulfate was seen for the cepI and cepR mutants. Flow cell analysis of the individual cepIR mutant biofilms indicated that they were both structurally and temporally impaired in attachment and development. These results suggest that biofilm structural defects might be present in quorum-sensing mutants of B. cenocepacia that affect the stability and resistance of the adherent cell mass, providing a basis for future studies to design preventative measures against biofilm formation in this species, an important lung pathogen of cystic fibrosis patients.
BJUI | 2007
J. Curtis Nickel; Dean A. Tripp; Shannon Chuai; Mark S. Litwin; Mary McNaughton-Collins; J. Richard Landis; Richard B. Alexander; Anthony J. Schaeffer; Michael P. O'Leary; Michel A. Pontari; Paige White; Christopher Mullins; Leroy M. Nyberg; John W. Kusek; Charles L. Bennett; Wade Bushman; Elizabeth A. Calhoun; Alisa E. Koch; Robert B. Nadler; Mary Healy; Marylin Dopona; Mary Buntin; Darlene S. Marko; James L. Duncan; Debra Rhodes; Judith Spolarich-Kroll; Alex Adler; Cindy Williams; Michael J. Barry; Dale Ardern
To examine interactions between demographic, pain, urinary, psychological and environmental predictors of quality of life (QOL) in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
The Journal of Urology | 1995
J. Curtis Nickel; Joe Downey; Janet Clark; Howard Ceri; Merle E. Olson
We hypothesized that altered pharmacokinetics in the inflamed prostate gland might account for the treatment failure of clinically diagnosed chronic bacterial prostatitis. We employed a rat model of chronic bacterial prostatitis to investigate any pharmacokinetic differences that may exist between uninflamed and inflamed prostate glands. Four groups of animals were studied (treated and untreated control and prostatitis groups). Seven days of norfloxacin therapy cured 60% of the animals with well-established bacterial prostatitis compared with a spontaneous cure rate of 10% in the nontreated prostatitis animals. Norfloxacin levels did not change significantly between the infected and noninfected prostate glands. We conclude that failure of antibiotic therapy in chronic bacterial prostatitis is not due to significantly altered norfloxacin pharmacokinetics in the chronically inflamed prostate gland but rather to the difficulty of eradicating protected bacterial microcolonies within an infection-induced altered microenvironment deep within the prostate gland.
Archive | 2001
Howard Ceri
Archive | 2006
Howard Ceri; Douglas W. Morck; Douglas G. Storey
Archive | 2002
Howard Ceri
Archive | 2006
Howard Ceri
Archive | 2010
Howard Ceri
Archive | 1993
Howard Ceri; Douglas W. Morck
Archive | 2004
Douglas G. Storey; Michael D. Parkins; Howard Ceri